Prolongation of clozapine-induced granulocytopenia associated with olanzapine [6]

Journal of Clinical Psychopharmacology

Volumn 17, Issue 6, 1997, Pages 494-495

  Flynn, S W ^a   Altman, S ^a   MacEwan, G W ^a   Black, L L ^a   Greenidge, L L ^a   Honer, W G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE;

BONE MARROW SUPPRESSION; CLINICAL ARTICLE; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG RESPONSE; GRANULOCYTOPENIA; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHIZOPHRENIA;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DRUG INTERACTIONS; HUMANS; PIRENZEPINE; SCHIZOPHRENIA;

EID: 0031396365     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199712000-00014     Document Type: Letter

References (4)